Rankings
▼
Calendar
BSX Q3 2024 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$105B
Q3 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$4.2B
+19.3% YoY
Gross Profit
$2.6B
62.9% margin
Operating Income
$674M
16.0% margin
Net Income
$469M
11.1% margin
EPS (Diluted)
$0.32
QoQ Revenue Growth
+2.2%
Cash Flow
Operating Cash Flow
$1.0B
Free Cash Flow
$698M
Stock-Based Comp.
-$61M
Balance Sheet
Total Assets
$38.1B
Total Liabilities
$17.1B
Stockholders' Equity
$20.7B
Cash & Equivalents
$2.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.2B
$3.5B
+19.3%
Gross Profit
$2.6B
$2.2B
+22.2%
Operating Income
$674M
$558M
+20.8%
Net Income
$469M
$504M
-6.9%
Revenue Segments
Cardiovascular
$2.7B
65%
MedSurg
$1.5B
35%
Geographic Segments
UNITED STATES
$2.6B
62%
Non-US
$1.6B
38%
← FY 2024
All Quarters
Q4 2024 →